Shattuck Labs Inc

Research Shattuck Labs Inc (STTK) on Bullrun: market cap USD 525.26M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSTTK
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 525.26M
• Financial periodFY2025
• RevenueUSD 1.00M
• Revenue growth-82.5%
• Net income-USD 48.81M
• Free cash flow-USD 39.95M

Valuation Snapshot

latest market cap is USD 525.26M.

About Shattuck Labs Inc

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study.

Frequently asked questions

What is Shattuck Labs Inc's market cap?

Shattuck Labs Inc's market capitalization is USD 525.26M.

What does Shattuck Labs Inc do?

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.